hexamethonium has been researched along with Diarrhea in 1 studies
Hexamethonium: A nicotinic cholinergic antagonist often referred to as the prototypical ganglionic blocker. It is poorly absorbed from the gastrointestinal tract and does not cross the blood-brain barrier. It has been used for a variety of therapeutic purposes including hypertension but, like the other ganglionic blockers, it has been replaced by more specific drugs for most purposes, although it is widely used a research tool.
Diarrhea: An increased liquidity or decreased consistency of FECES, such as running stool. Fecal consistency is related to the ratio of water-holding capacity of insoluble solids to total water, rather than the amount of water present. Diarrhea is not hyperdefecation or increased fecal weight.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lundgren, O | 1 |
| Peregrin, AT | 1 |
| Persson, K | 1 |
| Kordasti, S | 1 |
| Uhnoo, I | 1 |
| Svensson, L | 1 |
1 other study available for hexamethonium and Diarrhea
| Article | Year |
|---|---|
Role of the enteric nervous system in the fluid and electrolyte secretion of rotavirus diarrhea.
Topics: Animals; Animals, Newborn; Body Water; Diarrhea; Electrolytes; Enteric Nervous System; Hexamethonium | 2000 |